Mafalda Pagano

Title: Mafalda Pagano: Innovator in Pharmaceutical Chemistry

Introduction

Mafalda Pagano is a notable inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target lysophosphatidic acid receptors. With a total of 2 patents, her work is paving the way for new therapeutic options in treating various diseases.

Latest Patents

Mafalda's latest patents include innovative compounds that serve as inhibitors for lysophosphatidic acid receptors. The first patent focuses on amido cyclohexane acid derivatives as LPA receptor 1 inhibitors. This invention relates to compounds that inhibit lysophosphatidic acid receptor 1 (LPA1) and may be useful in treating conditions associated with a dysregulation of LPA receptors, particularly fibrosis. The second patent involves quinazoline derivatives as LPA receptor 2 inhibitors. This invention targets lysophosphatidic acid receptor 2 (LPA2) and also aims to address diseases linked to LPA receptor dysregulation, especially fibrosis.

Career Highlights

Mafalda Pagano is currently associated with Chiesi Farmaceutici S.p.a., where she continues her research and development efforts. Her work is characterized by a strong focus on creating pharmaceutical compositions that can lead to effective treatments for various medical conditions.

Collaborations

Mafalda collaborates with talented individuals such as Gabriele Amari and Elisabetta Armani. Their combined expertise enhances the innovative potential of their projects and contributes to the advancement of pharmaceutical research.

Conclusion

Mafalda Pagano's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a key innovator in the field. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of fibrosis and related conditions.